Loading...
Should Restrictions Be Relaxed for Metformin Use in Chronic Kidney Disease? No, We Should Never Again Compromise Safety!
Metformin is and has been considered as first-line therapy for type 2 diabetes for over a quarter of a century. Like other biguanides, metformin can cause a lactic acidosis that is exceptionally rare but fatal. The likelihood of metformin-associated lactic acidosis is substantially higher in patient...
Na minha lista:
| Udgivet i: | Diabetes Care |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Diabetes Association
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4915554/ https://ncbi.nlm.nih.gov/pubmed/27330129 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc15-2327 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|